title: Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer.
authors.affiliation: The Canberra Hospital, Australian National University Medical School, Canberra, Australia.
authors.forename: Desmond
authors.initials: D
authors.lastname: Yip
authors.forename: David
authors.initials: D
authors.lastname: Goldstein